First Time Loading...

AnGes Inc
TSE:4563

Watchlist Manager
AnGes Inc Logo
AnGes Inc
TSE:4563
Watchlist
Price: 49 JPY Market Closed
Updated: Apr 26, 2024

Intrinsic Value

AnGes Inc's intrinsic value estimate is unreliable because it is based only on its multiples and doesn't use a DCF valuation.

AnGes, Inc. engages in the research and development of gene-based medical products. [ Read More ]

The intrinsic value of one AnGes Inc stock under the Base Case scenario is 6.98 JPY. Compared to the current market price of 49 JPY, AnGes Inc is Overvalued by 86%.

Key Points:
Intrinsic Value
Base Case
6.98 JPY
Overvaluation 86%
Intrinsic Value
Price
Worst Case
Base Case
Best Case

Valuation Backtest
AnGes Inc

Backtest Intrinsic Value
Dive into the past to invest in the future

Run backtest to discover the historical profit from buying and selling AnGes Inc stocks based on their intrinsic value.

Analyze the historical link between intrinsic value and market price to make more informed investment decisions.

Run Backtest
Settings
Valuation Methods
Buy/Sell Thresholds
Buy When:
%
Sell When:
%
B
S
Run Backtest
How does it work?

Fundamental Analysis

Beta
Ask me anything about
AnGes Inc

Provide an overview of the primary business activities
of AnGes Inc.

What unique competitive advantages
does AnGes Inc hold over its rivals?

What risks and challenges
does AnGes Inc face in the near future?

Is it considered overvalued or undervalued
based on the latest financial data?

Show all valuation multiples
for AnGes Inc.

Provide P/S
for AnGes Inc.

Provide P/E
for AnGes Inc.

Provide P/OCF
for AnGes Inc.

Provide P/FCFE
for AnGes Inc.

Provide P/B
for AnGes Inc.

Provide EV/S
for AnGes Inc.

Provide EV/GP
for AnGes Inc.

Provide EV/EBITDA
for AnGes Inc.

Provide EV/EBIT
for AnGes Inc.

Provide EV/OCF
for AnGes Inc.

Provide EV/FCFF
for AnGes Inc.

Provide EV/IC
for AnGes Inc.

Show me price targets
for AnGes Inc made by professional analysts.

What are the Revenue projections
for AnGes Inc?

How accurate were the past Revenue estimates
for AnGes Inc?

What are the Net Income projections
for AnGes Inc?

How accurate were the past Net Income estimates
for AnGes Inc?

What are the EPS projections
for AnGes Inc?

How accurate were the past EPS estimates
for AnGes Inc?

What are the EBIT projections
for AnGes Inc?

How accurate were the past EBIT estimates
for AnGes Inc?

Compare the revenue forecasts
for AnGes Inc with those of its competitors based on recent analyst estimates.

Compare the intrinsic valuations
of AnGes Inc and its key competitors using the latest financial data.

Compare historical revenue growth rates
of AnGes Inc against its competitors.

Analyze the profit margins
(gross, operating, and net) of AnGes Inc compared to its peers.

Compare the P/E ratios
of AnGes Inc against its peers.

Discuss the investment returns and shareholder value creation
comparing AnGes Inc with its peers.

Analyze the financial leverage
of AnGes Inc compared to its main competitors.

Show all profitability ratios
for AnGes Inc.

Provide ROE
for AnGes Inc.

Provide ROA
for AnGes Inc.

Provide ROIC
for AnGes Inc.

Provide ROCE
for AnGes Inc.

Provide Gross Margin
for AnGes Inc.

Provide Operating Margin
for AnGes Inc.

Provide Net Margin
for AnGes Inc.

Provide FCF Margin
for AnGes Inc.

Show all solvency ratios
for AnGes Inc.

Provide D/E Ratio
for AnGes Inc.

Provide D/A Ratio
for AnGes Inc.

Provide Interest Coverage Ratio
for AnGes Inc.

Provide Altman Z-Score Ratio
for AnGes Inc.

Provide Quick Ratio
for AnGes Inc.

Provide Current Ratio
for AnGes Inc.

Provide Cash Ratio
for AnGes Inc.

What is the historical Revenue growth
over the last 5 years for AnGes Inc?

What is the historical Net Income growth
over the last 5 years for AnGes Inc?

What is the current Free Cash Flow
of AnGes Inc?

Discuss the annual earnings per share (EPS)
trend over the past five years for AnGes Inc.

Financials

Balance Sheet Decomposition
AnGes Inc

Current Assets 5.9B
Cash & Short-Term Investments 4.2B
Receivables 26.5m
Other Current Assets 1.7B
Non-Current Assets 23B
Long-Term Investments 355.5m
PP&E 423.1m
Intangibles 21.7B
Other Non-Current Assets 446.5m
Current Liabilities 2.5B
Accounts Payable 426.4m
Accrued Liabilities 130.2m
Other Current Liabilities 1.9B
Non-Current Liabilities 296.2m
Long-Term Debt 214.9m
Other Non-Current Liabilities 81.3m
Efficiency

Earnings Waterfall
AnGes Inc

Revenue
153m JPY
Cost of Revenue
-133.5m JPY
Gross Profit
19.4m JPY
Operating Expenses
-12B JPY
Operating Income
-12B JPY
Other Expenses
4.5B JPY
Net Income
-7.4B JPY

Free Cash Flow Analysis
AnGes Inc

Last Value
3-Years Average
FCF Margin
Conversion Rate
History
Components
Chart
Table
Fundamental Scores

Profitability Score
Profitability Due Diligence

AnGes Inc's profitability score is 25/100. The higher the profitability score, the more profitable the company is.

Exceptional 3-Years Revenue Growth
Exceptional 1-Year Revenue Growth
ROIC is Increasing
Declining ROE
25/100
Profitability
Score

AnGes Inc's profitability score is 25/100. The higher the profitability score, the more profitable the company is.

Solvency Score
Solvency Due Diligence

AnGes Inc's solvency score is 67/100. The higher the solvency score, the more solvent the company is.

Long-Term Solvency
Negative Net Debt
Low D/E
Short-Term Solvency
67/100
Solvency
Score

AnGes Inc's solvency score is 67/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

Price Targets Summary
AnGes Inc

There are no price targets for AnGes Inc.
Lowest
Price Target
Not Available
Average
Price Target
Not Available
Highest
Price Target
Not Available
View Analyst Estimates
View Analyst Estimates

Competitive Landscape

Shareholder Return

Price
AnGes Inc

1M 1M
-27%
6M 6M
-43%
1Y 1Y
-51%
3Y 3Y
-95%
5Y 5Y
-94%
10Y 10Y
-88%
Annual Price Range
49
52w Low
49
52w High
138
Price Metrics
Average Annual Return -16.33%
Standard Deviation of Annual Returns 80.19%
Max Drawdown -98%
Shares Statistics
Market Capitalization 9.7B JPY
Shares Outstanding 201 301 908
Percentage of Shares Shorted
N/A

Return Decomposition
Main factors of price return

What is price return decomposition?

Company Profile

AnGes Inc Logo
AnGes Inc

Country

Japan

Industry

Biotechnology

Market Cap

9.7B JPY

Dividend Yield

0%

Description

AnGes, Inc. engages in the research and development of gene-based medical products. The company is headquartered in Ibaraki-Shi, Osaka-Fu and currently employs 131 full-time employees. The company went IPO on 2002-09-25. The firm is involved in the development of hepatocyte growth factor (HGF) genetic medicines, NF-KB decoy oligo and hemagglutinating virus of Japan envelope (HVJ-E) non-viral vector, among others. As of December 31, 2012, the Company had four consolidated subsidiaries. On January 31, 2013, the Company sold a 95.3% stake of a Osaka-based subsidiary to ISHIHARA SANGYO KAISHA LTD.

Contact

OSAKA-FU
Ibaraki-shi
1F, Saito Bio-Incubator, 7-7-15, Saito-Asagi
+81357302641.0
https://www.anges.co.jp/

IPO

2002-09-25

Employees

131

Officers

CEO, President & Representative Director
Dr. Ei Yamada M.D., Ph.D.
Director of Corporate Development & Director
Mr. Naoya Sato

See Also

Discover More
What is the Intrinsic Value of one AnGes Inc stock?

The intrinsic value of one AnGes Inc stock under the Base Case scenario is 6.98 JPY.

Is AnGes Inc stock undervalued or overvalued?

Compared to the current market price of 49 JPY, AnGes Inc is Overvalued by 86%.